Skip to main content
. 2022 Mar;21(3):336–347.

Table 7.

Spirometry items of the patients during the study between inteventional and control groups

Visiting times

Baseline 4th Week 8th Week Difference of 1st to 4th Difference of 1st to 8th
FEV1 (%) A 64.97±20.45 73.95±19.28 74.63±18.28 8.97±10.30 9.66±10.42
B 66±18.05 70.42±18.28 71±17.97 4.42±5.44 5±7.06
p-value 0.578 0.394 0.304 0.011 0.009
FEV1 (L) A 1.98±0.75 2.33±0.83 2.38±0.77 0.34±0.54 0.39±0.53
B 2.06±0.75 2.18±0.75 2.20±0.71 0.12±0.3 0.14±0.36
p-value 0.575 0.448 0.337 0.044 0.028
MEF (%) A 45.45±22.08 59.39±28.69 61.92±27.90 13.95±19.23 16.47±20.66
B 47.29±22.66 54.72±27.45 58.16±29.52 7.42±18.51 10.87±18.62
p-value 0.659 0.519 0.499 0.067 0.232
MEF (L) A 1.68±0.96 2.12±1.12 2.18±1.08 0.43±0.65 0.5±0.71
B 1.63±84 1.83±1.06 1.95±1.08 0.2±0.63 0.32±0.62
p-value 0.913 0.285 0.321 0.097 0.209
FEV1/FVC A 64.87±8.26 72.71±8.96 73.42±9.58 7.84±8.68 8.55±8.75
B 64.92±7.57 67.11±8.57 68.11±9.12 2.18±8.67 3.18±8.78
p-value 0.978 0.011 0.019 0.001 0.003
*

p-value was tested with * Mann-Whitney U Test